| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |